| Genetic risk factors associated with NAFLD DY Kim, JY Park Hepatoma Res 6 (85), 10.20517, 2020 | 20 | 2020 |
| Genome‐wide association study identifies TNFSF15 associated with childhood asthma KW Kim, DY Kim, D Yoon, KK Kim, H Jang, N Schoettler, EG Kim, MN Kim, ... Allergy 77 (1), 218-229, 2022 | 17 | 2022 |
| Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance DY Kim, HW Lee, JE Song, BK Kim, SU Kim, DY Kim, SH Ahn, KH Han, ... Journal of medical virology 90 (3), 497-502, 2018 | 14 | 2018 |
| Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production DY Kim, JY Park, HY Gee Experimental & Molecular Medicine 55 (11), 2332-2345, 2023 | 11 | 2023 |
| Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study YE Chon, DY Kim, MN Kim, BK Kim, SU Kim, JY Park, SH Ahn, Y Ha, ... Clinical and molecular hepatology 30 (3), 345, 2024 | 9 | 2024 |
| LRRC6 regulates biogenesis of motile cilia by aiding FOXJ1 translocation into the nucleus DY Kim, YJ Sub, HY Kim, KJ Cho, WI Choi, YJ Choi, MG Lee, ... Cell Communication and Signaling 21 (1), 142, 2023 | 7 | 2023 |
| Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed? DY Kim, JY Park Hepatobiliary Surgery and Nutrition 8 (5), 522, 2019 | 7 | 2019 |
| Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models DY Kim, KS Chung, JY Park, HY Gee Biomedicine & Pharmacotherapy 161, 114445, 2023 | 5 | 2023 |
| Step-down strategy in antiviral resistant chronic hepatitis B patients who achieved viral suppression with rescue combination therapy DY Kim, JY Park Future Virology 13 (10), 711-717, 2018 | | 2018 |
